Canadian legislators just delivered another big win for cannabis investors.
On November 28, members of parliament (MP) overwhelmingly voted in favor of C-45, the bill is set to legalize recreational cannabis in the summer of 2018. The bill will now head to the Senate where it is expected to run into some resistance but ultimately pass.
A Private Member’s Bill by MP Dharamvir Gandhi to regulate cannabis and opium, and legalize medical marijuana, will be heard in the winter session of Parliament this December, according to a report by Indiatimes. Gandhi is a cardiologist, a former member of the Aam Aadmi Party (AAP) and presently a Member of Parliament from Patiala. Gandhi has been advocating the legalization of medical marijuana for many years, and received the support of late MP Vinod Khanna, among others. Continue reading “Marijuana Legalization Bill To Be Heard At India’s Parliament Winter Session”→
That’s right, two weeks to access our model portfolio which is up over 50% year-to-date.
You’ll also receive exclusive analysis and investment ideas, trade alerts for our model portfolio, and the ability to chat with our analyst, Michael Vodicka, and hundreds of other traders and investors excited about the cannabis sector!
Start your trial to learn about some of the stellar performers in our portfolio, including:
– A little-known Australian startup with an exclusive permit to grow and sell medical cannabis. Our members scored a 330% gain after our buy alert on July 31.
– An early global-leader in Canada ready to pounce on the country’s recreational market in the summer of 2018. Shares are up 145% since our buy signal went out.
If you decide that a CST membership isn’t a good fit for you, just contact us to cancel within your trial period. But if you love it (which we bet you will), you’ll continue as a member for only $29.99 – cancel anytime.